Namely, M010817 (NRASQ61K-mutated), M070302 (unknown mutation status), M150548 (BRAFV600E-mutated), MM150536 (BRAFV600E-mutated), WM1361A (NRASQ61R and PTEN +/−-mutated), and M121224 (NRASQ61K- and BRAFV600E-mutated) cells were subjected to different experimental setups to address aspects of proliferation, tumor growth, migration, and invasion (Fig. 3). This evidence concerns the gene PTEN and neoplasm.